1
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study
Condition(s):Bladder CancerLast Updated:September 11, 2019Recruiting
Bladder Cancer: 1350 Clinical Trials, Page 1 of 14
Hide Studies Not Open or Pending
2
Biomarker Identification for Bladder Cancer Patients
Condition(s):Bladder CancerLast Updated:April 12, 2017Unknown status
3
UroX Biomarker Bladder Cancer Study
Condition(s):Bladder CancerLast Updated:June 1, 2019Recruiting
4
Surveillance of High-grade Non-muscle Invasive Bladder Tumours Using the Xpert Bladder Cancer Monitor
Condition(s):Non-muscle Invasive Bladder Cancer; Urinary BiomarkerLast Updated:September 22, 2019Not yet recruiting
5
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
Condition(s):Bladder Cancer; Bladder Neoplasm; Bladder TumorLast Updated:September 6, 2019Recruiting
6
A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)
Condition(s):Non-muscle-invasive Bladder CancerLast Updated:April 12, 2019Recruiting
7
MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
Condition(s):Bladder CancerLast Updated:April 16, 2018Recruiting
8
The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study
Condition(s):Bladder CancerLast Updated:July 13, 2018Not yet recruiting
9
Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
Condition(s):Bladder CancerLast Updated:January 29, 2019Recruiting
10
Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9)
Condition(s):Bladder CancerLast Updated:April 16, 2018Recruiting
11
Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:August 15, 2019Recruiting
12
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
Condition(s):Bladder CancerLast Updated:December 13, 2016Not yet recruiting
13
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease
Condition(s):Bladder CancerLast Updated:June 21, 2013Completed
14
Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention
Condition(s):Bladder Cancer; Bladder Tumor; Urothelial CarcinomaLast Updated:September 6, 2019Not yet recruiting
15
Electromotive Mitomycin-C (EMDA-MMC) in Preventing Recurrences in High-risk Non-muscle-invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:April 23, 2019Recruiting
16
Genomic Imprinting Testing for Diagnosis of Bladder Cancer
Condition(s):Bladder Cancer; Urine Marking; Diagnoses DiseaseLast Updated:June 10, 2018Recruiting
17
The Potential Role Of MicroRNA-155 And Telomerase Reverse Transcriptase In Diagnosis Of Non-Muscle Invasive Bladder Cancer And Their Pathological Correlation
Condition(s):Bladder Cancer; Bladder Disease; Bladder Neoplasm; Micro-RNALast Updated:July 8, 2018Recruiting
18
Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer
Condition(s):Bladder CancerLast Updated:February 28, 2013Completed
19
Durvalumab Plus Olaparib Administered Prior to Surgery of Resectable Urothelial Bladder Cancer (NEODURVARIB)
Condition(s):Bladder CancerLast Updated:February 6, 2019Recruiting
20
Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors
Condition(s):Bladder CancerLast Updated:October 31, 2017Unknown status
21
Genetic Susceptibility to Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 24, 2019Recruiting
22
Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression
Condition(s):Bladder CancerLast Updated:July 31, 2019Not yet recruiting
23
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
Condition(s):Bladder CancerLast Updated:May 20, 2019Completed
24
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:June 7, 2019Withdrawn
25
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer
Condition(s):Muscle Invasive Bladder CancerLast Updated:August 9, 2019Active, not recruiting
26
High Resolution Imaging for Early and Better Detection of Bladder Cancer
Condition(s):Bladder CancerLast Updated:April 18, 2019Recruiting
27
Multidisciplinary Bladder-preservation Therapy for Bladder Cancer
Condition(s):Bladder CancerLast Updated:November 26, 2018Recruiting
28
Detection of K14 in Bladder Cancer With a Non Invasive Technique
Condition(s):Bladder CancerLast Updated:July 18, 2017Terminated
29
Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy “PROBE”
Condition(s):Bladder CancerLast Updated:July 2, 2019Recruiting
30
Autophagy Bladder Cancer
Condition(s):Bladder CancerLast Updated:July 4, 2019Not yet recruiting
31
Basal Tumours in Bladder Cancer, Response to chemoTherapy
Condition(s):Bladder Cancer; Chemotherapy EffectLast Updated:September 12, 2019Recruiting
32
Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:August 12, 2014Completed
33
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
Condition(s):Bladder CancerLast Updated:February 27, 2019Recruiting
34
The New England Bladder Cancer Study
Condition(s):Bladder CancerLast Updated:October 26, 2019Completed
35
Multi Institutional Study in Patient Presenting With Hematuria
Condition(s):Bladder Cancer; HematuriaLast Updated:March 5, 2019Active, not recruiting
36
Mood Disorders Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 30, 2019Recruiting
37
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors
Condition(s):Bladder CancerLast Updated:November 9, 2017Completed
38
Metformin and Simvastatin Use in Bladder Cancer
Condition(s):Bladder CancerLast Updated:July 7, 2016Unknown status
39
Quality of Life and Symptom Management in Patients With Bladder Cancer
Condition(s):Bladder CancerLast Updated:February 1, 2012Completed
40
An Educational Intervention for Patients With Bladder Cancer
Condition(s):Bladder CancerLast Updated:August 3, 2017Completed
41
PET/MRI and Biomarkers in Bladder Cancer
Condition(s):Bladder CancerLast Updated:April 16, 2018Completed
42
Prostate Capsule Sparing Cystectomy and Nerve-sparing Radical Cystoprostatectomy in Men With Bladder Cancer
Condition(s):Bladder Cancer; Transitional Cell Carcinoma of the BladderLast Updated:August 17, 2015Completed
43
Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer
Condition(s):Bladder CancerLast Updated:May 10, 2016Completed
44
Thulium Fiber Laser En-bloc Resection vs Conventional Transurethral Resection of Non-muscle-invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:September 27, 2019Completed
45
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
Condition(s):Bladder Cancer, BiomarkersLast Updated:August 9, 2018Completed
46
Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes
Condition(s):Diabetes; Bladder CancerLast Updated:February 6, 2018Completed
47
Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin
Condition(s):Invasive Bladder Cancer; Bladder CancerLast Updated:July 25, 2016Terminated
48
Cone Beam Computed Tomography (CT) Bladder
Condition(s):Bladder CancerLast Updated:April 24, 2019Completed
49
Urine-DNA Biomarkers in Detecting Bladder Cancer
Condition(s):Bladder Cancer; Biomarker; Diagnosis; UrineLast Updated:July 3, 2019Enrolling by invitation
50
Positron Emission Tomography (PET) Study for Staging of Muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 30, 2019Completed
51
Molecular Biosensors for Detection of Bladder Cancer
Condition(s):Urinary Bladder NeoplasmsLast Updated:October 10, 2018Recruiting
52
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study
Condition(s):Bladder CancerLast Updated:April 10, 2014Completed
53
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis
Condition(s):Bladder CancerLast Updated:June 10, 2019Recruiting
54
Multimodal Rehabilitation Program to Bladder Cancer Patients
Condition(s):Bladder CancerLast Updated:August 5, 2013Completed
55
Intravesical BCG Administration to Patients With Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:September 4, 2018Active, not recruiting
56
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
Condition(s):Bladder CancerLast Updated:May 11, 2015Recruiting
57
A Laser Detection for Bladder Cancer by (Photodynamic) Spectra of Urine
Condition(s):Transitional Cell Carcinoma of the BladderLast Updated:March 30, 2016Completed
58
Molecular Markers of Chemosensitivity for Bladder Cancer
Condition(s):Bladder Cancer; Effects of ChemotherapyLast Updated:February 27, 2014Unknown status
59
Determinants of Bladder Cancer Recurrence Study (The DETER Study)
Condition(s):Bladder CancerLast Updated:April 8, 2019Active, not recruiting
60
Prospective Study of Adjuvant Radiotherapy in High Risk Bladder Cancer.
Condition(s):Bladder CancerLast Updated:February 14, 2019Recruiting
61
Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
Condition(s):Bladder Cancer; Urinary BladderLast Updated:February 1, 2016Completed
62
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors
Condition(s):Bladder CancerLast Updated:May 8, 2018Recruiting
63
A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
Condition(s):Bladder CancerLast Updated:March 4, 2015Terminated
64
Quality of Life in Patients With Bladder Cancer
Condition(s):Bladder CancerLast Updated:September 6, 2019Active, not recruiting
65
Trimodality Therapy With/Out Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:September 10, 2019Recruiting
66
Improving Sensitivity of Urine Cytology for Bladder Cancer
Condition(s):Bladder CancerLast Updated:January 30, 2018Withdrawn
67
Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Condition(s):Bladder CancerLast Updated:August 9, 2018Terminated
68
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:November 6, 2018Active, not recruiting
69
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
Condition(s):Bladder CancerLast Updated:October 10, 2017Completed
70
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 28, 2015Completed
71
Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
Condition(s):Bladder Cancer; Urinary Cancer; Nonmuscle Invasive Bladder CancerLast Updated:December 16, 2015Completed
72
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
Condition(s):Muscle Invasive Bladder CancerLast Updated:February 22, 2019Recruiting
73
Ethacrynic Acid Elimination in Non-Muscle Invasive Bladder Cancer Patients Undergoing Transurethral Resection
Condition(s):Bladder CancerLast Updated:August 17, 2017Completed
74
Erlotinib Before and After Surgery in Treating Patients With Muscle-Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:June 20, 2017Completed
75
Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach
Condition(s):Invasive Bladder CancerLast Updated:January 7, 2019Recruiting
76
Evaluation Of Zetiq’s Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
Condition(s):Bladder Cancer Transitional Cell CarcinomaLast Updated:March 20, 2014Unknown status
77
Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
Condition(s):Bladder CancerLast Updated:September 7, 2017Completed
78
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Condition(s):Bladder Cancer; Urothelial CarcinomaLast Updated:September 27, 2019Recruiting
79
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 31, 2016Unknown status
80
Assessment of BladderLight SurvEILlance
Condition(s):Bladder CancerLast Updated:February 2, 2018Not yet recruiting
81
Laser vs. Electorsurgical Enbloc Resection of Bladder Tumours
Condition(s):Urinary Bladder NeoplasmLast Updated:July 24, 2019Recruiting
82
PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer
Condition(s):Bladder CancerLast Updated:January 23, 2017Completed
83
Diode Laser Treatment of Bladder Tumors
Condition(s):Bladder CancerLast Updated:May 30, 2017Completed
84
Comparison Study of Narrow Band Imaging Versus White Light Resection in Patients With Bladder Tumors/Cancer
Condition(s):Bladder CancerLast Updated:March 27, 2018Completed
85
Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 12, 2019Completed
86
Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Condition(s):Non Muscle Invasive Bladder CancerLast Updated:March 13, 2019Recruiting
87
Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
Condition(s):Bladder CancerLast Updated:October 17, 2017Withdrawn
88
Interdisciplinary Case-Control Study of Bladder Cancer in Spain
Condition(s):Bladder CancerLast Updated:September 28, 2019Completed
89
Complications of Transurethral Resection of the Bladder Tumour
Condition(s):Bladder CancerLast Updated:December 27, 2018Completed
90
Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer
Condition(s):Bladder CancerLast Updated:December 21, 2017Active, not recruiting
91
Confocal Microscopy Dual Band in the Management of Bladder Cancer
Condition(s):Urinary Bladder NeoplasmLast Updated:October 30, 2018Completed
92
Pembrolizumab With Chemoradiotherapy as Treatment for Muscle Invasive Bladder Cancer
Condition(s):Bladder CancerLast Updated:July 1, 2019Recruiting
93
Pilot Studie of Lipiodol Demarcation of the Tumour in Bladder Cancer
Condition(s):Bladder CancerLast Updated:December 4, 2015Completed
94
Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage
Condition(s):Bladder Cancer; Diagnoses Disease; Magnetic Resonance Imaging; Apparent Diffusion CoefficientLast Updated:May 16, 2017Unknown status
95
TURBt With Adjuvant Cryoablation to Treat Bladder Cancer
Condition(s):Urinary Bladder NeoplasmsLast Updated:October 17, 2017Unknown status
96
URINE-BASED DETECTION OF NON-MUSCLE INVASIVE BLADDER CANCER RECURRENCE
Condition(s):Bladder CancerLast Updated:May 23, 2019Not yet recruiting
97
Recovery Support for Bladder Cancer Patients and Caregivers
Condition(s):Invasive Bladder Cancer Stage II; Patient Engagement; Patient Empowerment; Ileal ConduitLast Updated:August 12, 2019Not yet recruiting
98
Atezolizumab and BCG in High Risk BCG naïve Non-muscle Invasive Bladder Cancer (NMIBC) Patients (BladderGATE)
Condition(s):Invasive Bladder CancerLast Updated:October 17, 2019Not yet recruiting
99
Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab
Condition(s):Bladder CancerLast Updated:June 7, 2019Active, not recruiting
100
Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer
Condition(s):Bladder CancerLast Updated:November 29, 2018Recruiting